{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:35:22Z","timestamp":1793381722484,"version":"4.5.0"},"reference-count":105,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T00:00:00Z","timestamp":1586217600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T00:00:00Z","timestamp":1586217600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s00223-020-00686-3","type":"journal-article","created":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T18:16:30Z","timestamp":1586283390000},"page":"3-15","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":191,"title":["Phosphate Metabolism in Health and Disease"],"prefix":"10.1007","volume":"108","author":[{"given":"Munro","family":"Peacock","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,7]]},"reference":[{"key":"686_CR1","first-page":"162","volume-title":"Calcium, Phosphate, and Magnesium Metabolism","author":"RW Marshall","year":"1976","unstructured":"Marshall RW (1976) Plasma Fractions. In: Nordin BEC (ed) Calcium, Phosphate, and Magnesium Metabolism. Churchill Livingstone, Edinburgh, pp 162\u2013185"},{"key":"686_CR2","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1136\/adc.57.3.217","volume":"57","author":"K Kruse","year":"1982","unstructured":"Kruse K, Kracht U, Gopfert G (1982) Renal threshold phosphate concentration (TmPO4\/GFR). Arch Dis Child 57:217\u2013223","journal-title":"Arch Dis Child"},{"issue":"Pt 3","key":"686_CR3","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1177\/000456328402100303","volume":"21","author":"JB Whitfield","year":"1984","unstructured":"Whitfield JB, Martin NG (1984) The effects of inheritance on constituents of plasma: a twin study on some biochemical variables. Ann Clin Biochem 21(Pt 3):176\u2013183","journal-title":"Ann Clin Biochem"},{"key":"686_CR4","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1042\/cs1030259","volume":"103","author":"DJ Hunter","year":"2002","unstructured":"Hunter DJ, Lange M, Snieder H, MacGregor AJ, Swaminathan R, Thakker RV, Spector TD (2002) Genetic contribution to renal function and electrolyte balance: a twin study. Clin Sci (Lond) 103:259\u2013265","journal-title":"Clin Sci (Lond)"},{"key":"686_CR5","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1172\/JCI113172","volume":"80","author":"AA Portale","year":"1987","unstructured":"Portale AA, Halloran BP, Morris RC Jr (1987) Dietary intake of phosphorus modulates the circadian rhythm in serum concentration of phosphorus. Implications for the renal production of 1,25-dihydroxyvitamin D. J Clin Invest 80:1147\u20131154","journal-title":"J Clin Invest"},{"key":"686_CR6","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1093\/ndt\/gft417","volume":"29","author":"KJ Martin","year":"2014","unstructured":"Martin KJ, Bell G, Pickthorn K, Huang S, Vick A, Hodsman P, Peacock M (2014) Velcalcetide (AMG 416), a novel peptide agonist of the calcium-sensing receptor, reduces serum parathyroid hormone and FGF23 levels in healthy male subjects. Nephrol Dial Transplant 29:385\u2013392","journal-title":"Nephrol Dial Transplant"},{"key":"686_CR7","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/S0736-4679(02)00578-4","volume":"23","author":"JR Shiber","year":"2002","unstructured":"Shiber JR, Mattu A (2002) Serum phosphate abnormalities in the emergency department. J Emerg Med 23:395\u2013400","journal-title":"J Emerg Med"},{"key":"686_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00005792-200001000-00001","volume":"79","author":"R Subramanian","year":"2000","unstructured":"Subramanian R, Khardori R (2000) Severe hypophosphatemia: Pathophysiologic implications, clinical presentations, and treatment. Medicine 79:1\u20138","journal-title":"Medicine"},{"key":"686_CR9","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1053\/j.ajkd.2013.03.042","volume":"62","author":"GA Block","year":"2013","unstructured":"Block GA, Ix JH, Ketteler M, Martin KJ, Thadhani RI, Tonelli M, Wolf M, Juppner H, Hruska K, Wheeler DC (2013) Phosphate homeostasis in CKD: report of a scientific symposium sponsored by the national kidney foundation. Am J Kidney Dis 62:457\u2013473","journal-title":"Am J Kidney Dis"},{"key":"686_CR10","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1053\/ajkd.1998.v31.pm9531176","volume":"31","author":"GA Block","year":"1998","unstructured":"Block GA, Hulbert-Shearon TE, Levin NW, Port FK (1998) Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis 31:607\u2013617","journal-title":"Am J Kidney Dis"},{"key":"686_CR11","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/sdi.12042","volume":"26","author":"MS Calvo","year":"2013","unstructured":"Calvo MS, Uribarri J (2013) Contributions to total phosphorus intake: all sources considered. Semin Dial 26:54\u201361","journal-title":"Semin Dial"},{"key":"686_CR12","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/jbm4.10026","volume":"2","author":"CJ Vorland","year":"2018","unstructured":"Vorland CJ, Martin BR, Weaver CM, Peacock M, Gallant KMH (2018) Phosphorus balance in adolescent girls and the effect of supplemental dietary calcium. JBMR Plus 2:103\u2013108","journal-title":"JBMR Plus"},{"key":"686_CR13","first-page":"1","volume-title":"DRI dietary reference intakes for calcium, phosphorus, magnesium, vitamin D, and fluoride","year":"1997","unstructured":"Medicine IO (ed) (1997) DRI dietary reference intakes for calcium, phosphorus, magnesium, vitamin D, and fluoride. The National Academies Press, Washington, DC, pp 1\u2013413"},{"key":"686_CR14","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/S0002-8223(98)00160-6","volume":"98","author":"AA Yates","year":"1998","unstructured":"Yates AA, Schlicker SA, Suitor CW (1998) Dietary Reference Intakes: the new basis for recommendations for calcium and related nutrients, B vitamins, and choline. J Am Diet Assoc 98:699\u2013706","journal-title":"J Am Diet Assoc"},{"key":"686_CR15","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.3945\/jn.111.142257","volume":"141","author":"VL Fulgoni 3rd","year":"2011","unstructured":"Fulgoni VL 3rd, Keast DR, Bailey RL, Dwyer J (2011) Foods, fortificants, and supplements: where do americans get their nutrients? J Nutr 141:1847\u20131854","journal-title":"J Nutr"},{"key":"686_CR16","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3945\/ajcn.112.053934","volume":"98","author":"MS Calvo","year":"2013","unstructured":"Calvo MS, Uribarri J (2013) Public health impact of dietary phosphorus excess on bone and cardiovascular health in the general population. Am J Clin Nutr 98:6\u201315","journal-title":"Am J Clin Nutr"},{"issue":"Suppl 2","key":"686_CR17","doi-asserted-by":"publisher","first-page":"S330","DOI":"10.1002\/mnfr.200900099","volume":"53","author":"U Schlemmer","year":"2009","unstructured":"Schlemmer U, Frolich W, Prieto RM, Grases F (2009) Phytate in foods and significance for humans: food sources, intake, processing, bioavailability, protective role and analysis. Mol Nutr Food Res 53(Suppl 2):S330\u2013375","journal-title":"Mol Nutr Food Res"},{"key":"686_CR18","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1056\/NEJM196802222780802","volume":"278","author":"M Lotz","year":"1968","unstructured":"Lotz M, Zisman E, Bartter FC (1968) Evidence for a phosphorus-depletion syndrome in man. N Engl J Med 278:409\u2013415","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"686_CR19","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.1016\/j.bone.2009.01.005","volume":"45","author":"JJ Kazama","year":"2009","unstructured":"Kazama JJ (2009) Oral phosphate binders: history and prospects. Bone 45(Suppl 1):S8\u201312","journal-title":"Bone"},{"key":"686_CR20","first-page":"36","volume-title":"Calcium phosphate and magnesium metabolism","author":"R Wilkinson","year":"1976","unstructured":"Wilkinson R (1976) Absorption of calcium, phosphorus and magnesium. In: Nordin BEC (ed) Calcium phosphate and magnesium metabolism. Churchill Livingstone, Edinburgh, pp 36\u2013112"},{"key":"686_CR21","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1201\/b16906-3","volume-title":"The physiological basis of metabolic bone disease","author":"JC Fleet","year":"2014","unstructured":"Fleet JC, Peacock M (2014) Physiology of vitamin D, calcium, and phosphate absorption. In: Morris AH, Anderson P, Nordin BEC (eds) The physiological basis of metabolic bone disease. CRC Press, Boca Raton, pp 13\u201340"},{"key":"686_CR22","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1053\/j.ackd.2010.11.004","volume":"18","author":"Y Sabbagh","year":"2011","unstructured":"Sabbagh Y, Giral H, Caldas Y, Levi M, Schiavi SC (2011) Intestinal phosphate transport. Adv Chronic Kidney Dis 18:85\u201390","journal-title":"Adv Chronic Kidney Dis"},{"key":"686_CR23","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1002\/ccr3.532","volume":"4","author":"L Stokman","year":"2016","unstructured":"Stokman L, Nossent EJ, Grunberg K, Meijboom L, Yakicier MC, Voorhoeve E, Houweling AC (2016) A case of pulmonary alveolar microlithiasis associated with a homozygous 195 kb deletion encompassing the entire SLC34A2 gene. Clin Case Rep 4:412\u2013415","journal-title":"Clin Case Rep"},{"key":"686_CR24","doi-asserted-by":"publisher","first-page":"G355","DOI":"10.1152\/ajpgi.00244.2016","volume":"312","author":"E Candeal","year":"2017","unstructured":"Candeal E, Caldas YA, Guillen N, Levi M, Sorribas V (2017) Intestinal phosphate absorption is mediated by multiple transport systems in rats. Am J Physiol Gastrointest Liver Physiol 312:G355\u2013G366","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"686_CR25","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1681\/ASN.2014030317","volume":"26","author":"ED Labonte","year":"2015","unstructured":"Labonte ED, Carreras CW, Leadbetter MR, Kozuka K, Kohler J, Koo-McCoy S, He L, Dy E, Black D, Zhong Z, Langsetmo I, Spencer AG, Bell N, Deshpande D, Navre M, Lewis JG, Jacobs JW, Charmot D (2015) Gastrointestinal inhibition of sodium-hydrogen exchanger 3 reduces phosphorus absorption and protects against vascular calcification in CKD. J Am Soc Nephrol 26:1138\u20131149","journal-title":"J Am Soc Nephrol"},{"key":"686_CR26","doi-asserted-by":"publisher","first-page":"eaam6474","DOI":"10.1126\/scitranslmed.aam6474","volume":"10","author":"AJ King","year":"2018","unstructured":"King AJ, Siegel M, He Y, Nie B, Wang J, Koo-McCoy S, Minassian NA, Jafri Q, Pan D, Kohler J, Kumaraswamy P, Kozuka K, Lewis JG, Dragoli D, Rosenbaum DP, O'Neill D, Plain A, Greasley PJ, Jonsson-Rylander AC, Karlsson D, Behrendt M, Stromstedt M, Ryden-Bergsten T, Knopfel T, Pastor Arroyo EM, Hernando N, Marks J, Donowitz M, Wagner CA, Alexander RT, Caldwell JS (2018) Inhibition of sodium\/hydrogen exchanger 3 in the gastrointestinal tract by tenapanor reduces paracellular phosphate permeability. Sci Transl Med 10:eaam6474","journal-title":"Sci Transl Med"},{"key":"686_CR27","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1681\/ASN.2016080855","volume":"28","author":"GA Block","year":"2017","unstructured":"Block GA, Rosenbaum DP, Leonsson-Zachrisson M, Astrand M, Johansson S, Knutsson M, Langkilde AM, Chertow GM (2017) Effect of tenapanor on serum phosphate in patients receiving hemodialysis. J Am Soc Nephrol 28:1933\u20131942","journal-title":"J Am Soc Nephrol"},{"key":"686_CR28","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1159\/000181989","volume":"26","author":"GS Walker","year":"1980","unstructured":"Walker GS, Peacock M, Marshall DH, Giles GR, Davison AM (1980) Factors influencing the intestinal absorption of calcium and phosphorus following renal transplantation. Nephron 26:225\u2013229","journal-title":"Nephron"},{"key":"686_CR29","doi-asserted-by":"publisher","first-page":"F39","DOI":"10.1152\/ajprenal.00375.2003","volume":"287","author":"H Segawa","year":"2004","unstructured":"Segawa H, Kaneko I, Yamanaka S, Ito M, Kuwahata M, Inoue Y, Kato S, Miyamoto K (2004) Intestinal Na-P(i) cotransporter adaptation to dietary P(i) content in vitamin D receptor null mice. Am J Physiol Renal Physiol 287:F39\u201347","journal-title":"Am J Physiol Renal Physiol"},{"key":"686_CR30","doi-asserted-by":"publisher","first-page":"C429","DOI":"10.1152\/ajpcell.00331.2004","volume":"288","author":"P Capuano","year":"2005","unstructured":"Capuano P, Radanovic T, Wagner CA, Bacic D, Kato S, Uchiyama Y, St-Arnoud R, Murer H, Biber J (2005) Intestinal and renal adaptation to a low-Pi diet of type II NaPi cotransporters in vitamin D receptor- and 1alphaOHase-deficient mice. Am J Physiol Cell Physiol 288:C429\u2013434","journal-title":"Am J Physiol Cell Physiol"},{"key":"686_CR31","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1677\/joe.0.0770225","volume":"77","author":"J Fox","year":"1978","unstructured":"Fox J, Care AD (1978) Effect of low calcium and low phosphorus diets on the intestinal absorption of phosphate in intact and parathyroidectomized pigs. J Endocrinol 77:225\u2013231","journal-title":"J Endocrinol"},{"key":"686_CR32","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1080\/00365521.1990.12067093","volume":"25","author":"G Danisi","year":"1990","unstructured":"Danisi G, Caverzasio J, Trechsel U, Bonjour JP, Straub RW (1990) Phosphate transport adaptation in rat jejunum and plasma level of 1,25-dihydroxyvitamin D3. Scand J Gastroenterol 25:210\u2013215","journal-title":"Scand J Gastroenterol"},{"key":"686_CR33","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1002\/jcph.570","volume":"56","author":"X Zhang","year":"2016","unstructured":"Zhang X, Imel EA, Ruppe MD, Weber TJ, Klausner MA, Ito T, Vergeire M, Humphrey J, Glorieux FH, Portale AA, Insogna K, Carpenter TO, Peacock M (2016) Pharmacokinetics and pharmacodynamics of a human monoclonal anti-FGF23 antibody (KRN23) in the first multiple ascending-dose trial treating adults with X-linked hypophosphatemia. J Clin Pharmacol 56:176\u2013185","journal-title":"J Clin Pharmacol"},{"key":"686_CR34","first-page":"618","volume":"38","author":"WD Armstrong","year":"1955","unstructured":"Armstrong WD (1955) Radioisotope studies of the physiology of calcified tissues. Minn Med 38:618\u2013622","journal-title":"Minn Med"},{"key":"686_CR35","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.2527\/jas.2006-082","volume":"84","author":"RS Dias","year":"2006","unstructured":"Dias RS, Kebreab E, Vitti DM, Roque AP, Bueno IC, France J (2006) A revised model for studying phosphorus and calcium kinetics in growing sheep. J Anim Sci 84:2787\u20132794","journal-title":"J Anim Sci"},{"key":"686_CR36","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1002\/jbmr.3175","volume":"32","author":"M Koide","year":"2017","unstructured":"Koide M, Kobayashi Y, Yamashita T, Uehara S, Nakamura M, Hiraoka BY, Ozaki Y, Iimura T, Yasuda H, Takahashi N, Udagawa N (2017) Bone formation is coupled to resorption via suppression of sclerostin expression by osteoclasts. J Bone Miner Res 32:2074\u20132086","journal-title":"J Bone Miner Res"},{"key":"686_CR37","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1177\/1759720X16670154","volume":"8","author":"B Langdahl","year":"2016","unstructured":"Langdahl B, Ferrari S, Dempster DW (2016) Bone modeling and remodeling: potential as therapeutic targets for the treatment of osteoporosis. Ther Adv Musculoskelet Dis 8:225\u2013235","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"686_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF02279101","volume":"4","author":"LF Belanger","year":"1969","unstructured":"Belanger LF (1969) Osteocytic osteolysis. Calcif Tissue Res 4:1\u201312","journal-title":"Calcif Tissue Res"},{"key":"686_CR39","first-page":"1","volume":"229","author":"JJ Wysolmerski","year":"2012","unstructured":"Wysolmerski JJ (2012) Osteocytic osteolysis: time for a second look. BoneKEy Rep 229:1\u20137","journal-title":"BoneKEy Rep"},{"key":"686_CR40","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1007\/s00223-019-00569-2","volume":"105","author":"NK Wittig","year":"2019","unstructured":"Wittig NK, Birkbak ME, Bach-Gansmo FL, Pacureanu A, Wendelboe MH, Bruel A, Thomsen JS, Birkedal H (2019) No Signature of osteocytic osteolysis in cortical bone from lactating NMRI Mice. Calcif Tissue Int 105:308\u2013315","journal-title":"Calcif Tissue Int"},{"key":"686_CR41","doi-asserted-by":"publisher","first-page":"17044","DOI":"10.1038\/nrdp.2017.44","volume":"3","author":"S Minisola","year":"2017","unstructured":"Minisola S, Peacock M, Fukumoto S, Cipriani C, Pepe J, Tella SH, Collins MT (2017) Tumour-induced osteomalacia. Nat Rev Dis Primers 3:17044","journal-title":"Nat Rev Dis Primers"},{"key":"686_CR42","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1358\/dof.2010.035.09.1526651","volume":"35","author":"EA Imel","year":"2010","unstructured":"Imel EA, Peacock M (2010) X-linked hypophosphatemia: understanding and management. Drugs Fut 35:755\u2013763","journal-title":"Drugs Fut"},{"key":"686_CR43","first-page":"83","volume-title":"Metabolic bone and stone disease","author":"M Peacock","year":"1993","unstructured":"Peacock M (1993) Osteomalacia and rickets. In: Nordin BEC, Need AG, Morris HA (eds) Metabolic bone and stone disease. Churchill Livingstone, London, pp 83\u2013118"},{"key":"686_CR44","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1116\/1.2354575","volume":"1","author":"L Wang","year":"2006","unstructured":"Wang L, Nancollas GH, Henneman ZJ, Klein E, Weiner S (2006) Nanosized particles in bone and dissolution insensitivity of bone mineral. Biointerphases 1:106\u2013111","journal-title":"Biointerphases"},{"key":"686_CR45","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.bbrc.2012.04.077","volume":"422","author":"CM Cowan","year":"2012","unstructured":"Cowan CM, Zhang X, James AW, Kim TM, Sun N, Wu B, Ting K, Soo C (2012) NELL-1 increases pre-osteoblast mineralization using both phosphate transporter Pit1 and Pit2. Biochem Biophys Res Commun 422:351\u2013357","journal-title":"Biochem Biophys Res Commun"},{"key":"686_CR46","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1677\/joe.0.1810531","volume":"181","author":"E Zoidis","year":"2004","unstructured":"Zoidis E, Ghirlanda-Keller C, Gosteli-Peter M, Zapf J, Schmid C (2004) Regulation of phosphate (Pi) transport and NaPi-III transporter (Pit-1) mRNA in rat osteoblasts. J Endocrinol 181:531\u2013540","journal-title":"J Endocrinol"},{"key":"686_CR47","doi-asserted-by":"publisher","first-page":"e0125104","DOI":"10.1371\/journal.pone.0125104","volume":"10","author":"G Albano","year":"2015","unstructured":"Albano G, Moor M, Dolder S, Siegrist M, Wagner CA, Biber J, Hernando N, Hofstetter W, Bonny O, Fuster DG (2015) Sodium-dependent phosphate transporters in osteoclast differentiation and function. PLoS ONE 10:e0125104","journal-title":"PLoS ONE"},{"key":"686_CR48","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1359\/jbmr.020603","volume":"21","author":"A Suzuki","year":"2006","unstructured":"Suzuki A, Ghayor C, Guicheux J, Magne D, Quillard S, Kakita A, Ono Y, Miura Y, Oiso Y, Itoh M, Caverzasio J (2006) Enhanced expression of the inorganic phosphate transporter Pit-1 is involved in BMP-2-induced matrix mineralization in osteoblast-like cells. J Bone Miner Res 21:674\u2013683","journal-title":"J Bone Miner Res"},{"key":"686_CR49","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.bbagen.2017.11.005","volume":"1862","author":"M Bottini","year":"2018","unstructured":"Bottini M, Mebarek S, Anderson KL, Strzelecka-Kiliszek A, Bozycki L, Simao AMS, Bolean M, Ciancaglini P, Pikula JB, Pikula S, Magne D, Volkmann N, Hanein D, Millan JL, Buchet R (2018) Matrix vesicles from chondrocytes and osteoblasts: Their biogenesis, properties, functions and biomimetic models. Biochim Biophys Acta Gen Subj 1862:532\u2013546","journal-title":"Biochim Biophys Acta Gen Subj"},{"key":"686_CR50","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1007\/s12551-017-0315-1","volume":"9","author":"M Bolean","year":"2017","unstructured":"Bolean M, Simao AMS, Barioni MB, Favarin BZ, Sebinelli HG, Veschi EA, Janku TAB, Bottini M, Hoylaerts MF, Itri R, Millan JL, Ciancaglini P (2017) Biophysical aspects of biomineralization. Biophys Rev 9:747\u2013760","journal-title":"Biophys Rev"},{"key":"686_CR51","doi-asserted-by":"publisher","first-page":"e10202","DOI":"10.1002\/jbm4.10202","volume":"3","author":"S Dillon","year":"2019","unstructured":"Dillon S, Staines KA, Millan JL, Farquharson C (2019) How To Build a Bone: PHOSPHO1, Biomineralization, and Beyond. JBMR Plus 3:e10202","journal-title":"JBMR Plus"},{"issue":"63","key":"686_CR52","first-page":"102","volume":"2013","author":"MD McKee","year":"2000","unstructured":"McKee MD, Hoac B, Addison WN, Barros NM, Millan JL, Chaussain C (2000) Extracellular matrix mineralization in periodontal tissues: Noncollagenous matrix proteins, enzymes, and relationship to hypophosphatasia and X-linked hypophosphatemia. Periodontol 2013(63):102\u2013122","journal-title":"Periodontol"},{"key":"686_CR53","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s00223-012-9672-8","volume":"93","author":"JL Millan","year":"2013","unstructured":"Millan JL (2013) The Role of Phosphatases in the Inititiation of Skeletal Mineralization. Calcif Tiss Int 93:299\u2013306","journal-title":"Calcif Tiss Int"},{"key":"686_CR54","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1159\/000151375","volume":"189","author":"NE Hatch","year":"2009","unstructured":"Hatch NE, Franceschi RT (2009) Osteoblast differentiation stage-specific expression of the pyrophosphate-generating enzyme PC-1. Cells Tissues Org 189:65\u201369","journal-title":"Cells Tissues Org"},{"key":"686_CR55","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.bone.2017.12.004","volume":"107","author":"BL Foster","year":"2018","unstructured":"Foster BL, Ao M, Salmon CR, Chavez MB, Kolli TN, Tran AB, Chu EY, Kantovitz KR, Yadav M, Narisawa S, Millan JL, Nociti FH Jr, Somerman MJ (2018) Osteopontin regulates dentin and alveolar bone development and mineralization. Bone 107:196\u2013207","journal-title":"Bone"},{"key":"686_CR56","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1177\/154411130401500302","volume":"15","author":"C Qin","year":"2004","unstructured":"Qin C, Baba O, Butler WT (2004) Post-translational modifications of sibling proteins and their roles in osteogenesis and dentinogenesis. Crit Rev Oral Biol Med 15:126\u2013136","journal-title":"Crit Rev Oral Biol Med"},{"key":"686_CR57","doi-asserted-by":"publisher","first-page":"e7038","DOI":"10.1371\/journal.pone.0007038","volume":"4","author":"TL Kelly","year":"2009","unstructured":"Kelly TL, Wilson KE, Heymsfield SB (2009) Dual energy X-Ray absorptiometry body composition reference values from NHANES. PLoS ONE 4:e7038","journal-title":"PLoS ONE"},{"key":"686_CR58","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1002\/nbm.1192","volume":"20","author":"GJ Kemp","year":"2007","unstructured":"Kemp GJ, Meyerspeer M, Moser E (2007) Absolute quantification of phosphorus metabolite concentrations in human muscle in vivo by 31P MRS: a quantitative review. NMR Biomed 20:555\u2013565","journal-title":"NMR Biomed"},{"key":"686_CR59","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1042\/cs0710729","volume":"71","author":"A Bevington","year":"1986","unstructured":"Bevington A, Mundy KI, Yates AJ, Kanis JA, Russell RG, Taylor DJ, Rajagopalan B, Radda GK (1986) A study of intracellular orthophosphate concentration in human muscle and erythrocytes by 31P nuclear magnetic resonance spectroscopy and selective chemical assay. Clin Sci (Lond) 71:729\u2013735","journal-title":"Clin Sci (Lond)"},{"key":"686_CR60","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1038\/ki.1996.135","volume":"49","author":"MP Kavanaugh","year":"1996","unstructured":"Kavanaugh MP, Kabat D (1996) Identification and characterization of a widely expressed phosphate transporter\/retrovirus receptor family. Kidney Int 49:959\u2013963","journal-title":"Kidney Int"},{"key":"686_CR61","doi-asserted-by":"publisher","first-page":"3378","DOI":"10.1096\/fj.201600473R","volume":"30","author":"DH Pesta","year":"2016","unstructured":"Pesta DH, Tsirigotis DN, Befroy DE, Caballero D, Jurczak MJ, Rahimi Y, Cline GW, Dufour S, Birkenfeld AL, Rothman DL, Carpenter TO, Insogna K, Petersen KF, Bergwitz C, Shulman GI (2016) Hypophosphatemia promotes lower rates of muscle ATP synthesis. FASEB J 30:3378\u20133387","journal-title":"FASEB J"},{"key":"686_CR62","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1007\/s00726-011-0877-3","volume":"40","author":"T Wallimann","year":"2011","unstructured":"Wallimann T, Tokarska-Schlattner M, Schlattner U (2011) The creatine kinase system and pleiotropic effects of creatine. Amino Acids 40:1271\u20131296","journal-title":"Amino Acids"},{"key":"686_CR63","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.ecl.2018.07.009","volume":"47","author":"M Peacock","year":"2018","unstructured":"Peacock M (2018) Hypoparathyroidism and the Kidney. Endocrinol Metab Clin North Am 47:839\u2013853","journal-title":"Endocrinol Metab Clin North Am"},{"key":"686_CR64","doi-asserted-by":"publisher","first-page":"F643","DOI":"10.1152\/ajprenal.00228.2007","volume":"293","author":"LV Virkki","year":"2007","unstructured":"Virkki LV, Biber J, Murer H, Forster IC (2007) Phosphate transporters: a tale of two solute carrier families. Am J Physiol Renal Physiol 293:F643\u2013654","journal-title":"Am J Physiol Renal Physiol"},{"key":"686_CR65","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1146\/annurev-physiol-030212-183748","volume":"75","author":"J Biber","year":"2013","unstructured":"Biber J, Hernando N, Forster I (2013) Phosphate transporters and their function. Annu Rev Physiol 75:535\u2013550","journal-title":"Annu Rev Physiol"},{"key":"686_CR66","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00424-018-2207-z","volume":"471","author":"IC Forster","year":"2019","unstructured":"Forster IC (2019) The molecular mechanism of SLC34 proteins: insights from two decades of transport assays and structure-function studies. Pflugers Arch 471:15\u201342","journal-title":"Pflugers Arch"},{"key":"686_CR67","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.mam.2012.07.007","volume":"34","author":"IC Forster","year":"2013","unstructured":"Forster IC, Hernando N, Biber J, Murer H (2013) Phosphate transporters of the SLC20 and SLC34 families. Mol Aspects Med 34:386\u2013395","journal-title":"Mol Aspects Med"},{"key":"686_CR68","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1681\/ASN.2018121250","volume":"30","author":"L Thomas","year":"2019","unstructured":"Thomas L, Xue J, Murali SK, Fenton RA, Dominguez Rieg JA, Rieg T (2019) Pharmacological Npt2a inhibition causes phosphaturia and reduces plasma phosphate in mice with normal and reduced kidney function. J Am Soc Nephrol 30:2128\u20132139","journal-title":"J Am Soc Nephrol"},{"key":"686_CR69","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1681\/ASN.2016070726","volume":"28","author":"C Ansermet","year":"2016","unstructured":"Ansermet C, Moor MB, Centeno G, Auberson M, Hu DZ, Baron R, Nikolaeva S, Haenzi B, Katanaeva N, Gautschi I, Katanaev V, Rotman S, Koesters R, Schild L, Pradervand S, Bonny O, Firsov D (2016) Renal fanconi syndrome and hypophosphatemic rickets in the absence of xenotropic and polytropic retroviral receptor in the nephron. J Am Soc Nephrol 28:1073\u20131078","journal-title":"J Am Soc Nephrol"},{"key":"686_CR70","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/0009-8981(69)90280-0","volume":"26","author":"OL Bijvoet","year":"1969","unstructured":"Bijvoet OL, Morgan DB, Fourman P (1969) The assessment of phosphate reabsorption. Clin Chim Acta 26:15\u201324","journal-title":"Clin Chim Acta"},{"key":"686_CR71","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S0140-6736(75)92736-1","volume":"2","author":"RJ Walton","year":"1975","unstructured":"Walton RJ, Bijvoet OL (1975) Nomogram for derivation of renal threshold phosphate concentration. Lancet 2:309\u2013310","journal-title":"Lancet"},{"key":"686_CR72","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1359\/jbmr.060507","volume":"21","author":"SM Burnett","year":"2006","unstructured":"Burnett SM, Gunawardene SC, Bringhurst FR, Juppner H, Lee H, Finkelstein JS (2006) Regulation of C-terminal and intact FGF-23 by dietary phosphate in men and women. J Bone Miner Res 21:1187\u20131196","journal-title":"J Bone Miner Res"},{"key":"686_CR73","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1210\/jc.2004-1039","volume":"90","author":"SL Ferrari","year":"2005","unstructured":"Ferrari SL, Bonjour JP, Rizzoli R (2005) Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men. J Clin Endocrinol Metab 90:1519\u20131524","journal-title":"J Clin Endocrinol Metab"},{"key":"686_CR74","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/039139889802100104","volume":"21","author":"AH Lau","year":"1998","unstructured":"Lau AH, Kuk JM, Franson KL (1998) Phosphate-binding capacities of calcium and aluminum formulations. Int J Artif Organs 21:19\u201322","journal-title":"Int J Artif Organs"},{"key":"686_CR75","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1111\/j.1464-410X.1978.tb06189.x","volume":"50","author":"WG Robertson","year":"1978","unstructured":"Robertson WG, Peacock M, Heyburn PJ, Marshall DH, Clark PB (1978) Risk factors in calcium stone disease of the urinary tract. Br J Urol 50:449\u2013454","journal-title":"Br J Urol"},{"key":"686_CR76","first-page":"549","volume":"6","author":"A Hodgkinson","year":"1969","unstructured":"Hodgkinson A, Peacock M, Nicholson M (1969) Quantitative analysis of calcium-containing urinary calculi. Invest Urol 6:549\u2013561","journal-title":"Invest Urol"},{"key":"686_CR77","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s00240-010-0271-8","volume":"38","author":"FL Coe","year":"2010","unstructured":"Coe FL, Evan AP, Worcester EM, Lingeman JE (2010) Three pathways for human kidney stone formation. Urol Res 38:147\u2013160","journal-title":"Urol Res"},{"key":"686_CR78","doi-asserted-by":"publisher","first-page":"3985","DOI":"10.1113\/jphysiol.2014.273979","volume":"592","author":"E Lederer","year":"2014","unstructured":"Lederer E (2014) Regulation of serum phosphate. J Physiol 592:3985\u20133995","journal-title":"J Physiol"},{"key":"686_CR79","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s11154-015-9318-z","volume":"16","author":"JE Blau","year":"2015","unstructured":"Blau JE, Collins MT (2015) The PTH-Vitamin D-FGF23 axis. Rev Endocr Metab Disord 16:165\u2013174","journal-title":"Rev Endocr Metab Disord"},{"key":"686_CR80","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1359\/JBMR.0301264","volume":"19","author":"T Shimada","year":"2004","unstructured":"Shimada T, Hasegawa H, Yamazaki Y, Muto T, Hino R, Takeuchi Y, Fujita T, Nakahara K, Fukumoto S, Yamashita T (2004) FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res 19:429\u2013435","journal-title":"J Bone Miner Res"},{"key":"686_CR81","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1038\/ng1905","volume":"38","author":"JQ Feng","year":"2006","unstructured":"Feng JQ, Ward LM, Liu S, Lu Y, Xie Y, Yuan B, Yu X, Rauch F, Davis SI, Zhang S, Rios H, Drezner MK, Quarles LD, Bonewald LF, White KE (2006) Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism. Nat Genet 38:1310\u20131315","journal-title":"Nat Genet"},{"key":"686_CR82","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1097\/MNH.0b013e32832c224f","volume":"18","author":"JQ Feng","year":"2009","unstructured":"Feng JQ, Ye L, Schiavi S (2009) Do osteocytes contribute to phosphate homeostasis? Curr Opin Nephrol Hypertens 18:285\u2013291","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"686_CR83","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s00774-007-0779-3","volume":"25","author":"N Ito","year":"2007","unstructured":"Ito N, Fukumoto S, Takeuchi Y, Takeda S, Suzuki H, Yamashita T, Fujita T (2007) Effect of acute changes of serum phosphate on fibroblast growth factor (FGF)23 levels in humans. J Bone Miner Metab 25:419\u2013422","journal-title":"J Bone Miner Metab"},{"key":"686_CR84","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/nature05315","volume":"444","author":"I Urakawa","year":"2006","unstructured":"Urakawa I, Yamazaki Y, Shimada T, Iijima K, Hasegawa H, Okawa K, Fujita T, Fukumoto S, Yamashita T (2006) Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature 444:770\u2013774","journal-title":"Nature"},{"key":"686_CR85","doi-asserted-by":"publisher","first-page":"6120","DOI":"10.1074\/jbc.C500457200","volume":"281","author":"H Kurosu","year":"2006","unstructured":"Kurosu H, Ogawa Y, Miyoshi M, Yamamoto M, Nandi A, Rosenblatt KP, Baum MG, Schiavi S, Hu MC, Moe OW, Kuro M (2006) Regulation of fibroblast growth factor-23 signaling by klotho. J Biol Chem 281:6120\u20136123","journal-title":"J Biol Chem"},{"key":"686_CR86","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1111\/j.1523-1755.2005.00506.x","volume":"68","author":"M Baum","year":"2005","unstructured":"Baum M, Schiavi S, Dwarakanath V, Quigley R (2005) Effect of fibroblast growth factor-23 on phosphate transport in proximal tubules. Kidney Int 68:1148\u20131153","journal-title":"Kidney Int"},{"key":"686_CR87","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1172\/JCI200419081","volume":"113","author":"T Shimada","year":"2004","unstructured":"Shimada T, Kakitani M, Yamazaki Y, Hasegawa H, Takeuchi Y, Fujita T, Fukumoto S, Tomizuka K, Yamashita T (2004) Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J Clin Invest 113:561\u2013568","journal-title":"J Clin Invest"},{"key":"686_CR88","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1053\/j.ackd.2011.01.004","volume":"18","author":"C Bergwitz","year":"2011","unstructured":"Bergwitz C, Juppner H (2011) Phosphate sensing. Adv Chronic Kidney Dis 18:132\u2013144","journal-title":"Adv Chronic Kidney Dis"},{"key":"686_CR89","doi-asserted-by":"publisher","first-page":"57","DOI":"10.5414\/CN107322","volume":"79","author":"Y Sabbagh","year":"2013","unstructured":"Sabbagh Y (2013) Phosphate as a sensor and signaling molecule. Clin Nephrol 79:57\u201365","journal-title":"Clin Nephrol"},{"key":"686_CR90","doi-asserted-by":"publisher","first-page":"11418","DOI":"10.1073\/pnas.1815166116","volume":"116","author":"Y Takashi","year":"2019","unstructured":"Takashi Y, Kosako H, Sawatsubashi S, Kinoshita Y, Ito N, Tsoumpra MK, Nangaku M, Abe M, Matsuhisa M, Kato S, Matsumoto T, Fukumoto S (2019) Activation of unliganded FGF receptor by extracellular phosphate potentiates proteolytic protection of FGF23 by its O-glycosylation. Proc Natl Acad Sci USA 116:11418\u201311427","journal-title":"Proc Natl Acad Sci USA"},{"key":"686_CR91","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.molmet.2018.02.007","volume":"11","author":"N Bon","year":"2018","unstructured":"Bon N, Frangi G, Sourice S, Guicheux J, Beck-Cormier S, Beck L (2018) Phosphate-dependent FGF23 secretion is modulated by PiT2\/Slc20a2. Mol Metab 11:197\u2013204","journal-title":"Mol Metab"},{"key":"686_CR92","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.kint.2018.03.006","volume":"94","author":"P Glosse","year":"2018","unstructured":"Glosse P, Feger M, Mutig K, Chen H, Hirche F, Hasan AA, Gaballa MMS, Hocher B, Lang F, Foller M (2018) AMP-activated kinase is a regulator of fibroblast growth factor 23 production. Kidney Int 94:491\u2013501","journal-title":"Kidney Int"},{"key":"686_CR93","doi-asserted-by":"publisher","first-page":"3541","DOI":"10.1210\/jc.2011-1239","volume":"96","author":"EA Imel","year":"2011","unstructured":"Imel EA, Peacock M, Gray AK, Padgett LR, Hui SL, Econs MJ (2011) Iron Modifies Plasma FGF23 Differently in Autosomal Dominant Hypophosphatemic Rickets and Healthy Humans. J Clin Endocrinol Metab 96:3541\u20133549","journal-title":"J Clin Endocrinol Metab"},{"key":"686_CR94","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1002\/jbmr.1923","volume":"28","author":"M Wolf","year":"2013","unstructured":"Wolf M, Koch TA, Bregman DB (2013) Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women. J Bone Miner Res 28:1793\u20131803","journal-title":"J Bone Miner Res"},{"key":"686_CR95","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/jbmr.2049","volume":"29","author":"EL Clinkenbeard","year":"2014","unstructured":"Clinkenbeard EL, Farrow EG, Summers LJ, Cass TA, Roberts JL, Bayt CA, Lahm T, Albrecht M, Allen MR, Peacock M, White KE (2014) Neonatal iron deficiency causes abnormal phosphate metabolism by elevating FGF23 in normal and ADHR mice. J Bone Miner Res 29:361\u2013369","journal-title":"J Bone Miner Res"},{"key":"686_CR96","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1046\/j.1523-1755.2001.00064.x","volume":"60","author":"KE White","year":"2001","unstructured":"White KE, Carn G, Lorenz-Depiereux B, Benet-Pages A, Strom TM, Econs MJ (2001) Autosomal-dominant hypophosphatemic rickets (ADHR) mutations stabilize FGF-23. Kidney Int 60:2079\u20132086","journal-title":"Kidney Int"},{"key":"686_CR97","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1097\/01.mnh.0000447020.74593.6f","volume":"23","author":"M Wolf","year":"2014","unstructured":"Wolf M, White KE (2014) Coupling fibroblast growth factor 23 production and cleavage: iron deficiency, rickets, and kidney disease. Curr Opin Nephrol Hypertens 23:411\u2013419","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"686_CR98","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1359\/jbmr.1999.14.11.1848","volume":"14","author":"JC Estepa","year":"1999","unstructured":"Estepa JC, Aguilera-Tejero E, Lopez I, Almaden Y, Rodriguez M, Felsenfeld AJ (1999) Effect of phosphate on parathyroid hormone secretion in vivo. J Bone Miner Res 14:1848\u20131854","journal-title":"J Bone Miner Res"},{"key":"686_CR99","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1677\/JOE-07-0267","volume":"195","author":"T Krajisnik","year":"2007","unstructured":"Krajisnik T, Bjorklund P, Marsell R, Ljunggren O, Akerstrom G, Jonsson KB, Westin G, Larsson TE (2007) Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells. J Endocrinol 195:125\u2013131","journal-title":"J Endocrinol"},{"key":"686_CR100","first-page":"4003","volume":"117","author":"IZ Ben-Dov","year":"2007","unstructured":"Ben-Dov IZ, Galitzer H, Lavi-Moshayoff V, Goetz R, Kuro M, Mohammadi M, Sirkis R, Naveh-Many T, Silver J (2007) The parathyroid is a target organ for FGF23 in rats. J Clin Invest 117:4003\u20134008","journal-title":"J Clin Invest"},{"key":"686_CR101","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1172\/JCI108137","volume":"56","author":"BS Chertow","year":"1975","unstructured":"Chertow BS, Baylink DJ, Wergedal JE, Su MH, Norman AW (1975) Decrease in serum immunoreactive parathyroid hormone in rats and in parathyroid hormone secretion in vitro by 1,25-dihydroxycholecalciferol. J Clin Invest 56:668\u2013678","journal-title":"J Clin Invest"},{"key":"686_CR102","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.bbrc.2005.01.033","volume":"328","author":"T Jaaskelainen","year":"2005","unstructured":"Jaaskelainen T, Huhtakangas J, Maenpaa PH (2005) Negative regulation of human parathyroid hormone gene promoter by vitamin D3 through nuclear factor Y. Biochem Biophys Res Commun 328:831\u2013837","journal-title":"Biochem Biophys Res Commun"},{"key":"686_CR103","doi-asserted-by":"publisher","first-page":"G1036","DOI":"10.1152\/ajpgi.00243.2005","volume":"289","author":"OI Kolek","year":"2005","unstructured":"Kolek OI, Hines ER, Jones MD, LeSueur LK, Lipko MA, Kiela PR, Collins JF, Haussler MR, Ghishan FK (2005) 1alpha,25-Dihydroxyvitamin D3 upregulates FGF23 gene expression in bone: the final link in a renal-gastrointestinal-skeletal axis that controls phosphate transport. Am J Physiol Gastrointest Liver Physiol 289:G1036\u2013G1042","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"686_CR104","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.bone.2011.06.025","volume":"49","author":"Y Rhee","year":"2011","unstructured":"Rhee Y, Bivi N, Farrow E, Lezcano V, Plotkin LI, White KE, Bellido T (2011) Parathyroid hormone receptor signaling in osteocytes increases the expression of fibroblast growth factor-23 in vitro and in vivo. Bone 49:636\u2013643","journal-title":"Bone"},{"issue":"Suppl 1","key":"686_CR105","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.2215\/CJN.05910809","volume":"5","author":"M Peacock","year":"2010","unstructured":"Peacock M (2010) Calcium metabolism in health and disease. Clin J Am Soc Nephrol 5(Suppl 1):S23\u201330","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-020-00686-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00223-020-00686-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-020-00686-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T13:25:48Z","timestamp":1695993948000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00223-020-00686-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,7]]},"references-count":105,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["686"],"URL":"https:\/\/doi.org\/10.1007\/s00223-020-00686-3","relation":{},"ISSN":["0171-967X","1432-0827"],"issn-type":[{"value":"0171-967X","type":"print"},{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,7]]},"assertion":[{"value":"4 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Munro Peacock declare that they have no competing interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}